Meridian Bioscience Q3 Adj. EPS $0.22 Misses $0.31 Estimate, Sales $63.51M Miss $77.22M Estimate
Meridian Bioscience (NASDAQ:VIVO) reported quarterly earnings of $0.22 per share which missed the analyst consensus estimate of $0.31 by 29.03 percent. This is a 60 percent decrease over earnings of $0.55 per share from